Skip to content
healthcare.dev

LINZESS

NDC 50090-8108, linaclotide, capsule, gelatin coated, from A-S Medication Solutions.

Product NDC
50090-8108
Status
Listed
Labeler
A-S Medication Solutions
Dosage form
CAPSULE, GELATIN COATED
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA202811
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/50090-8108 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • LINACLOTIDE145 ug/1

Pharmacologic classes

Guanylate Cyclase Activators [MoA]; Guanylate Cyclase-C Agonist [EPC]

Package NDCNDC-11Package
50090-8108-0500908108001 BOTTLE in 1 CARTON (50090-8108-0) / 30 CAPSULE, GELATIN COATED in 1 BOTTLE

Linked data

RxNorm, label and prices

RxNorm concepts

RxNorm links no concept to this product's packages.

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/2d09771d-69da-4c9d-92b6-74374ffa130f

Use it

Look up 50090-8108 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/50090-8108 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 50090-8108. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.